Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 179 results.
User Information
Export Records
  1. 1.   Aberrant CD8+T cells drive reproductive dysfunction in female mice with elevated IFN-gamma levels
  2. Bafor, Enitome E; Erwin-Cohen, Rebecca A; Martin, Toni; Baker, Clayton; Kimmel, Adrienne E; Duverger, Olivier; Fenimore, John M; Ramba, Meredith; Spindel, Thea; Hess, Megan M; Sanford, Michael; Lazarevic, Vanja; Benayoun, Bérénice A; Young, Howard A; Valencia, Julio C
  3. Frontiers in Immunology. 2024, Apr 18; 15: 1368572.
  1. 2.   Interferon induced circRNAs escape herpesvirus host shutoff and suppress lytic infection
  2. Dremel, Sarah E; Tagawa, Takanobu; Koparde,Vishal; Hernandez-Perez, Carmen; Arbuckle, Jesse H; Kristie, Thomas M; Krug, Laurie T; Ziegelbauer, Joseph M
  3. EMBO Reports. 2024, Mar; 25(3): 1541-1569.
  1. 3.   Use of human peripheral blood mononuclear cells to define immunological properties of nucleic acid nanoparticles
  2. Dobrovolskaia,Marina; Afonin, Kirill A
  3. Nature protocols. 2020, Oct 23; 15(11): 3678-3698.
  1. 4.   Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology
  2. Afonin, Kirill A.; Dobrovolskaia,Marina; Church, George; Bathe, Mark
  3. ACS NANO. 2020, AUG 25; 14(8): 9221-9227.
  1. 5.   Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption
  2. Mitchell, Julie L.; Takata, Hiroshi; Muir, Roshell; Colby, Donn J.; Kroon, Eugene; Crowell, Trevor A.; Sacdalan, Carlo; Pinyakorn, Suteeraporn; Puttamaswin, Suwanna; Benjapornpong, Khunthalee; Trichavaroj, Rapee; Tressler, Randall L.; Fox, Lawrence; Polonis, Victoria R.; Bolton, Diane L.; Maldarelli,Frank; Lewin, Sharon R.; Haddad, Elias K.; Phanuphak, Praphan; Robb, Merlin L.; Michael, Nelson L.; de Souza, Mark; Phanuphak, Nittaya; Ananworanich, Jintanat; Trautmann, Lydie
  3. JOURNAL OF CLINICAL INVESTIGATION. 2020, JUN 1; 130(6): 2845-2858.
  1. 6.   Adaptive in vivo device for theranostics of inflammation: real-time monitoring of interferon-? and aspirin
  2. Cao, Chaomin; Jin, Ronghua; Wei, Hui; Liu, Zhongning; Ni, Shengnan; Liu, Guo-Jun; Young,Howard; Chen, Xin; Liu, Guozhen
  3. Acta biomaterialia. 2020, Jan 1; 101: 372-383.
  1. 7.   Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
  2. Kayraklioglu, Neslihan; Scheiermann, Julia; Alvord, W. Gregory; Klinman, Dennis
  3. MOLECULAR THERAPY-NUCLEIC ACIDS. 2017, Sep 15; 8: 243-249.
  1. 8.   Suppressed Type 1, Type 2, and Type 17 Cytokine Responses in Active Tuberculosis in Children
  2. Kumar, N. P.; Anuradha, R.; Suresh, R.; Ganesh, R.; Shankar, J.; Kumaraswami, V.; Nutman, T. B.; Babu, S.
  3. Clinical and Vaccine Immunology. 2011, Nov; 18(11): 1856-1864.
  1. 9.   CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues
  2. Sisirak, V.; Vey, N.; Vanbervliet, B.; Duhen, T.; Puisieux, I.; Homey, B.; Bowman, E. P.; Trinchieri, G.; Dubois, B.; Kaiserlian, D.; Lira, S. A.; Puisieux, A.; Blay, J. Y.; Caux, C.; Bendriss-Vermare, N.
  3. Blood. 2011, Nov; 118(19): 5130-5140.
  1. 10.   Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death
  2. Boulware, D. R.; Hullsiek, K. H.; Puronen, C. E.; Rupert, A.; Baker, J. V.; French, M. A.; Bohjanen, P. R.; Novak, R. M.; Neaton, J. D.; Sereti, I.; Grp, I. S.
  3. Journal of Infectious Diseases. 2011, Jun; 203(11): 1637-1646.
  1. 11.   Secretoglobin 3A2 Suppresses Bleomycin-induced Pulmonary Fibrosis by Transforming Growth Factor beta Signaling Down-regulation
  2. Kurotani, R.; Okumura, S.; Matsubara, T.; Yokoyama, U.; Buckley, J. R.; Tomita, T.; Kezuka, K.; Nagano, T.; Esposito, D.; Taylor, T. E.; Gillette, W. K.; Ishikawa, Y.; Abe, H.; Ward, J. M.; Kimura, S.
  3. Journal of Biological Chemistry. 2011, Jun; 286(22): 19682-19692.
  1. 12.   Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
  2. Buhtoiarov, I. N.; Sondel, P. M.; Wigginton, J. M.; Buhtoiarova, T. N.; Yanke, E. M.; Mahvi, D. A.; Rakhmilevich, A. L.
  3. Immunology. 2011, Feb; 132(2): 226-239.
  1. 13.   Cloning of guinea pig IL-4: Reduced IL-4 mRNA after vaccination or Mycobacterium tuberculosis infection
  2. Jeevan, A.; Yoshimura, T.; Ly, L. H.; Dirisala, V. R.; McMurray, D. N.
  3. Tuberculosis. 2011, Jan; 91(1): 47-56.
  1. 14.   CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus
  2. Katsounas, A.; Schlaak, J. F.; Lempicki, R. A.
  3. International Reviews of Immunology. 2011, Oct-Dec; 30(5-6): 366-378.
  1. 15.   IL28B Polymorphism Does Not Determine Outcomes of Hepatitis B Virus or HIV Infection
  2. Martin, M. P.; Qi, Y.; Goedert, J. J.; Hussain, S. K.; Kirk, G. D.; Hoots, W. K.; Buchbinder, S.; Carrington, M.; Thio, C. L.
  3. Journal of Infectious Diseases. 2010, Dec; 202(11): 1749-1753.
  1. 16.   Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
  2. Libutti, S. K.; Paciotti, G. F.; Byrnes, A. A.; Alexander, H. R.; Gannon, W. E.; Walker, M.; Seidel, G. D.; Yuldasheva, N.; Tamarkin, L.
  3. Clinical Cancer Research. 2010, Dec; 16(24): 6139-6149.
  1. 17.   Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
  2. Kuhns, D. B.; Alvord, W. G.; Heller, T.; Feld, J. J.; Pike, K. M.; Marciano, B. E.; Uzel, G.; DeRavin, S. S.; Priel, D. A. L.; Soule, B. P.; Zarember, K. A.; Malech, H. L.; Holland, S. M.; Gallin, J. I.
  3. New England Journal of Medicine. 2010, Dec; 363(27): 2600-2610.
  1. 18.   Evidence of dysregulation of dendritic cells in primary HIV infection
  2. Sabado, R. L.; O'Brien, M.; Subedi, A.; Qin, L.; Hu, N.; Taylor, E.; Dibben, O.; Stacey, A.; Fellay, J.; Shianna, K. V.; Siegal, F.; Shodell, M.; Shah, K.; Larsson, M.; Lifson, J.; Nadas, A.; Marmor, M.; Hutt, R.; Margolis, D.; Garmon, D.; Markowitz, M.; Valentine, F.; Borrow, P.; Bhardwaj, N.
  3. Blood. 2010, Nov; 116(19): 3839-3852.
  1. 19.   STAT1 activation regulates proliferation and differentiation of renal progenitors
  2. Wang, H.; Yang, Y.; Sharma, N.; Tarasova, N. I.; Timofeeva, O. A.; Winkler-Pickett, R. T.; Tanigawa, S.; Perantoni, A. O.
  3. Cellular Signalling. 2010, Nov; 22(11): 1717-1726.
  1. 20.   Interleukin-26: An IL-10-related cytokine produced by Th17 cells
  2. Donnelly, R. P.; Sheikh, F.; Dickensheets, H.; Savan, R.; Young, H. A.; Walter, M. R.
  3. Cytokine & Growth Factor Reviews. 2010, Oct; 21(5): 393-401.
  1. 21.   Tumor-Specific CD8(+) T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
  2. Kerkar, S. P.; Muranski, P.; Kaiser, A.; Boni, A.; Sanchez-Perez, L.; Yu, Z. Y.; Palmer, D. C.; Reger, R. N.; Borman, Z. A.; Zhang, L.; Morgan, R. A.; Gattinoni, L.; Rosenberg, S. A.; Trinchieri, G.; Restifo, N. P.
  3. Cancer Research. 2010, Sep; 70(17): 6725-6734.
  1. 22.   NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway
  2. Watanabe, T.; Asano, N.; Fichtner-Feigl, S.; Gorelick, P. L.; Tsuji, Y.; Matsumoto, Y.; Chiba, T.; Fuss, I. J.; Kitani, A.; Strober, W.
  3. Journal of Clinical Investigation. 2010, May; 120(5): 1645-1662.
  1. 23.   Kinetics of Serum Cytokines after Primary or Repeat Vaccination with the Smallpox Vaccine
  2. Cohen, J. I.; Hohman, P.; Fulton, R.; Turk, S. P.; Qin, J.; Thatcher, K.; Hornung, R. L.
  3. Journal of Infectious Diseases. 2010, Apr; 201(8): 1183-1191.
  1. 24.   Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants
  2. Klinman, D. M.; Klaschik, S.; Tomaru, K.; Shirota, H.; Tross, D.; Ikeuchi, H.
  3. Vaccine. 2010, Feb; 28(8): 1919-1923.
  1. 25.   The Path Well Traveled: Using Mammalian Retroviruses to Guide Research on XMRV
  2. Lee, K.; Jones, K. S.
  3. Molecular Interventions. 2010, Feb; 10(1): 20-24.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel